Stay updated on Pembrolizumab Reirradiation in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Reirradiation in Glioblastoma Clinical Trial page.

Latest updates to the Pembrolizumab Reirradiation in Glioblastoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe revision line on the page updated from v3.6.3 to v3.6.4. This represents a minor update to the page's version information.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, indicating a deployment/maintenance update to the ClinicalTrials.gov page. This change represents behind-the-scenes maintenance rather than modifications to study details or content.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, indicating a software version update for the page. No study content or data is changed by this update.SummaryDifference0.0%

- Check53 days agoChange DetectedA new note 'No longer looking for participants' was added, signaling that recruitment for the study is closed. The page also includes new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates to the Intervention/Treatment heading and the revision footer (Revision: v3.6.0).SummaryDifference0.4%

- Check60 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, indicating a newer document revision. This update does not change any displayed study details or user-facing content.SummaryDifference0.0%

- Check81 days agoChange DetectedThe revision tag on the page was updated to v3.5.4, replacing the previous v3.5.3. This indicates a software/document version update rather than a change to study content.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Reirradiation in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Reirradiation in Glioblastoma Clinical Trial page.